Efficacy News and Research

RSS

Biomaterial-based vaccine has potential to completely eliminate AML cells

Acute myeloid leukemia (AML) is a deadly blood cancer that originates in the bone marrow and kills most of its victims within five years. Chemotherapy has been the standard AML treatment for over 40 years, and while it often causes the cancer to go into remission, it rarely completely eliminates the cancerous cells, which then lead to disease recurrence in nearly half of treated patients.

14 Jan 2020

Probiotic drink could offer novel way to fight antibiotic-resistant bacteria

A probiotic drink could become a promising new weapon in the battle against antibiotic-resistant bacteria, after a team of Birmingham scientists engineered and patented a key genetic element that can tackle the genetic basis of resistance.

14 Jan 2020

Orthopaedic Research UK announces £140,000 investment in biotech startup

Orthopaedic Research UK has announced that biotech startup, Renovos, will receive the first investment from its newly launched the Ronald Furlong Fund, a partnership between ORUK and HS., established this year in memory of the charity’s founder.

14 Jan 2020

Researchers evaluate epinephrine use for treatment of pediatric OHCA

A loved one suffering cardiac arrest is an emotionally stressful time for families, but never more so than when the patient is a child. The very real potential for loss of life in these situations means that the way in which emergency responders treat out of hospital cardiac arrest (OHCA) becomes even more crucial when dealing with pediatric patients.

14 Jan 2020

NUS researchers discover new personalized tool for cancer diagnosis

A team of researchers from the National University of Singapore has discovered a new personalized tool to detect cancer, predict patient survivability and how well a cancer patient would respond to immunotherapy.

14 Jan 2020

Long-term antipsychotic therapy for schizophrenia is safe

Researchers at Karolinska Institutet in Sweden and their colleagues in Germany, the USA and Finland have studied the safety of very long-term antipsychotic therapy for schizophrenia.

11 Jan 2020

Local pollution sources have tremendous impact on air quality in Delhi

The University of Surrey has revealed results from a new, comprehensive study that suggests that activities such as construction and vehicle traffic contribute significantly to the Delhi National Capital Region's high concentrations of harmful air pollutants and gases.

10 Jan 2020

Evolution of Antibiotic Tolerance Promotes Resistance to Combination Regimens

A new study suggests that the evolution of antibiotic tolerance requires further investigation if newly designed antibiotic treatments are going to be able to prevent drug-resistant infections.

10 Jan 2020

Timing is key: preventing infant SHIV infection by PEP

Researchers tested methods to prevent development of SHIV, an infection similar to HIV, in infant macaque monkeys.

9 Jan 2020

Immune cells could help kill cancer cells, finds study

Researchers from UCL Cancer Institute have found that a subset of immune cells can kill cancer cells when activated.

8 Jan 2020

Researchers capture light emission from the eye of a patient undergoing radiotherapy

For decades, theories have existed to explain patient reports of seeing light flashes during radiation therapy, even with their eyes closed.

7 Jan 2020

Updated guideline for management of osteoarthritis of the hand, hip and knee released

Today, the American College of Rheumatology, in partnership with the Arthritis Foundation, released the 2019 ACR/AF Guideline for the Management of Osteoarthritis of the Hand, Hip and Knee.

7 Jan 2020

Mayo Clinic researchers seek radical new approach to treat cocaine addition

In a radical new approach to treat cocaine addition, researchers at the Mayo Clinic are seeking approval for first-in-human studies of a single-dose gene therapy.

7 Jan 2020

Clinical trial tests experimental stem cell treatment against best available drugs for MS

A clinical trial has begun testing an experimental stem cell treatment against the best available biologic therapies for severe forms of relapsing multiple sclerosis.

7 Jan 2020

Dana-Farber Cancer Institute to create Chen-Huang Center for EGFR Mutant Lung Cancers

Dana-Farber Cancer Institute will create the Chen-Huang Center for EGFR (epidermal growth factor receptor) Mutant Lung Cancers to stimulate research, promote clinical trials, and strengthen the Institute's capabilities for studying and treating lung cancer.

7 Jan 2020

Interplay between relaxin and Wnt signaling has positive effects on aging heart

As a healthy heart ages, it becomes more susceptible to cardiovascular diseases. Though researchers have discovered that relaxin, an insulin-like hormone, suppresses atrial fibrillation (AF), inflammation, and fibrosis in aged rats, the underlying mechanisms of these benefits are still unknown.

7 Jan 2020